8-KLeadership ChangesCorporate ChangesOther Events+1

Corteva, Inc. 8-K Report, Executive Changes (Oct 10, 2019)

Filed October 10, 2019For Securities:CTVA

Summary

This 8-K filing from Corteva, Inc. (CTVA) on October 10, 2019, primarily announces the upcoming retirement of Senior Vice President and Chief Technology Officer, Dr. Neal Gutterson, in the second half of 2020. Dr. Gutterson will remain with the company until a successor is appointed and a smooth transition is ensured, with an executive search firm already engaged for recruitment. This signals a key leadership transition in the company's technological and research functions. The filing also details amendments to the company's bylaws concerning deadlines for the 2020 Annual Meeting of Stockholders. These amendments refine the timing for submitting stockholder proposals, director nominations, and proxy access nominations, providing clarity for investors and stakeholders planning to engage with the company at its next annual meeting.

Key Highlights

  • 1Senior Vice President and Chief Technology Officer, Dr. Neal Gutterson, intends to retire in the second half of 2020.
  • 2Dr. Gutterson will stay with Corteva until a successor is identified and transition is complete.
  • 3An executive recruitment firm has been engaged to find a replacement for the CTO position.
  • 4Corteva's Bylaws were amended effective October 8, 2019, to adjust deadlines for the 2020 Annual Meeting of Stockholders.
  • 5Deadlines for stockholder proposals, director nominations, and proxy access nominations for the 2020 Annual Meeting have been clarified.
  • 6The 2020 Annual Meeting of Stockholders is anticipated to be held around April 28, 2020.

Frequently Asked Questions

Dr. Gutterson's retirement as Senior Vice President and Chief Technology Officer marks a significant leadership change in Corteva's innovation and technology strategy. Investors will be keen to see who succeeds him and how the company's R&D and technological development plans may evolve under new leadership.

Dr. Gutterson intends to retire in the second half of 2020. He has agreed to stay with the company until his successor is selected and a period thereafter to ensure a smooth transition. The exact timeline will depend on the recruitment process.

The company's bylaws were amended to better align and clarify certain deadlines related to the 2020 Annual Meeting of Stockholders. This includes setting specific windows for submitting stockholder proposals, director nominations, and proxy access nominations, ensuring proper procedural timelines are met for shareholder engagement.

While the exact date is subject to the Board of Directors' final decision, the 2020 Annual Meeting is expected around April 28, 2020. Key submission deadlines for stockholder proposals under Rule 14a-8 are December 2, 2019. For business proposals and director nominations outside of proxy access, notice must be received between November 21, 2019, and December 21, 2019. For director nominations through proxy access, notice must be received between October 22, 2019, and November 21, 2019.